Yashiro N, Ohtomo K, Itai Y, Iio M
Br J Radiol. 1985 Jun;58(690):503-9. doi: 10.1259/0007-1285-58-690-503.
CT and angiography of five solitary renal hamartomas not associated with tuberous sclerosis are reviewed. CT revealed fat in four hamartomas and was the more reliable in the differentiation from renal cancer. Bleeding from the tumour was detected in two cases and the extent of each haematoma was precisely determined by CT. Angiography showed specific findings in only one tumour. In a pararenal hamartoma, angiography was of value in clarifying the renal origin of the tumour. Though angiography may be of help when CT is inconclusive, we think it should not be relied upon as a major diagnostic tool and we utilise it mainly for preoperative mapping and embolisation. In one case CT did not detect fat and preoperative diagnosis was impossible. In one case with haematoma, detection of fat was difficult. We believe potential hamartomas with no detectable fat should be treated as malignancy until proved otherwise. There seems to be discrepancy between the vascularity of the hamartoma and the degree of contrast enhancement (CE) with a bolus injection method; hamartomas seem to show weaker CE than that expected for renal cancer of equal vascularity, a fact which may differentiate solitary hamartoma from cancer.
回顾了5例不伴有结节性硬化症的孤立性肾错构瘤的CT及血管造影表现。CT显示4例错构瘤内有脂肪,在与肾癌的鉴别诊断中更具可靠性。2例肿瘤发生出血,CT精确测定了各血肿的范围。血管造影仅在1例肿瘤中显示出特异性表现。在1例肾旁错构瘤中,血管造影有助于明确肿瘤的肾源性。虽然当CT诊断不明确时血管造影可能有帮助,但我们认为不应将其作为主要诊断工具,主要用于术前定位和栓塞。1例CT未检测到脂肪,无法进行术前诊断。1例伴有血肿的病例中,脂肪检测困难。我们认为,在未证实之前,未检测到脂肪的潜在错构瘤应按恶性肿瘤处理。错构瘤的血管分布与团注法对比增强(CE)程度之间似乎存在差异;错构瘤的CE似乎比同等血管分布的肾癌预期的要弱,这一事实可能有助于孤立性错构瘤与癌症的鉴别。